In one case study, a T1D patient receiving anti-TNFα treatment (etanercept) for arthritis lost stable control of her blood glucose levels, where they were described as “erratic” and lead to severe hypoglycemic attacks without warning, having previously had stable control (202). The gene discussed is TNF; the disease is arthritic joint disease.